These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 6754142)

  • 1. Systematic study of the hydrolysis of 4-methylumbelliferylguanidinobenzoate in plasma from patients with cystic fibrosis and controls.
    Tümmler B; Seger E; Riordan JR
    Clin Chim Acta; 1982 Oct; 125(2):219-32. PubMed ID: 6754142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protease deficiency in plasma of patients with cystic fibrosis. Reduced reaction of 4-methylumbelliferylguanidinobenzoate with plasma of patients with cystic fibrosis.
    Walsh-Platt M; Rao GJ; Nadler HL
    Enzyme; 1979; 24(4):224-9. PubMed ID: 488055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of the major 4-methylumbelliferyl p-guanidinobenzoate-hydrolyzing plasma protein in cystic fibrosis: implication for intrauterine and heterozygote detection.
    Branchini BR; Salituro GM; Rosenstein BJ
    Pediatr Res; 1983 Nov; 17(11):850-5. PubMed ID: 6646895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reaction of 4-methylumbelliferylguanidinobenzoate with cultivated human skin fibroblasts derived from patients with cystic fibrosis.
    Platt MW; Rao GJ; Nadler HL
    Pediatr Res; 1978 Aug; 12(8):874-7. PubMed ID: 683746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prenatal diagnosis of cystic fibrosis by methylumbelliferylguanidinobenzoate protease titration in amniotic fluid.
    Brock DJ; Hayward C
    Prenat Diagn; 1983 Jan; 3(1):1-5. PubMed ID: 6341979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reaction of 4-methylumbelliferylguanidinobenzoate with proteases in human amniotic fluid.
    Walsh MM; Rao GJ; Nadler HL
    Pediatr Res; 1980 Apr; 14(4 Pt 1):353-6. PubMed ID: 6990368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reaction of 4-methylumbelliferylguanidinobenzoate with proteases in plasma of patients with cystic fibrosis.
    Rao GJ; Platt MW; Nadler HL
    Enzyme; 1978; 23(5):314-9. PubMed ID: 710382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrauterine detection of cystic fibrosis.
    Nadler HL; Walsh MM
    Pediatrics; 1980 Nov; 66(5):690-2. PubMed ID: 7001334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 4-methylumbelliferylguanidinobenzoate reactive plasma "protease" in cystic fibrosis is albumin.
    Branchini BR; Salituro GM; Rosenstein BJ; Bruns WT
    Lancet; 1982 Mar; 1(8272):618-9. PubMed ID: 6121200
    [No Abstract]   [Full Text] [Related]  

  • 10. A serine protease activity of human serum albumin towards 4-methylumbelliferyl-guanidinobenzoate (MUGB) and diisopropyl fluorophosphate (DEP): implications for the use of MUGB reactivity in amniotic fluid in prenatal diagnosis of cystic fibrosis.
    Schwartz M
    Clin Chim Acta; 1982 Sep; 124(2):213-23. PubMed ID: 6754141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylumbelliferylguanidinobenzoate-reactive proteases in human amniotic fluid: Promising marker for the intrauterine detection of cystic fibrosis.
    Walsh MM; Nadler HL
    Am J Obstet Gynecol; 1980 Aug; 137(8):978-82. PubMed ID: 6996486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. False-negative results with methylumbelliferylguanidinobenzoate reactive proteases in cystic fibrosis pregnancies.
    Schwartz M; Brandt NJ
    Lancet; 1981 Nov; 2(8257):1226. PubMed ID: 6118647
    [No Abstract]   [Full Text] [Related]  

  • 13. Prenatal detection of cystic fibrosis.
    Nadler HL; Rembelski P; Meserow K; Gerbie AB
    Am J Obstet Gynecol; 1981 Dec; 141(8):885-9. PubMed ID: 7315920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carrier detection in cystic fibrosis.
    Qureshi AR; Punnett HH
    J Pediatr; 1985 Jun; 106(6):913-7. PubMed ID: 3998947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue-type plasminogen activator and urokinase: differences in the reaction pattern with the active-site titrant 4-methylumbelliferyl-p-guanidinobenzoate hydrochloride.
    Geiger M; Binder BR
    Biochim Biophys Acta; 1987 Mar; 912(1):34-40. PubMed ID: 3103686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reaction of tissue-type plasminogen activator with 4-methylumbelliferyl-p-guanidinobenzoate hydrochloride.
    Urano T; Urano S; Castellino FJ
    Biochem Biophys Res Commun; 1988 Jan; 150(1):45-51. PubMed ID: 3122757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylumbelliferyl-guanidinobenzoate reactive proteases in amniotic fluid: possible marker for cystic fibrosis.
    Walsh MM; Nadler HL
    Lancet; 1979 Mar; 1(8116):622. PubMed ID: 85228
    [No Abstract]   [Full Text] [Related]  

  • 18. Rapid high-performance liquid chromatographic method for the measurement of hymecromon and its conjugates in blood plasma or serum at concentrations attained during therapy.
    Femfert U; Kuntz HD; May B
    J Chromatogr; 1983 Dec; 278(2):452-7. PubMed ID: 6668328
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies on cystic fibrosis using isoelectric focusing. II. Demonstration of deficient proteolytic cleavage of alpha2-macroglobulin in cystic fibrosis plasma.
    Wilson GB; Fudenberg HH
    Pediatr Res; 1976 Feb; 10(2):87-96. PubMed ID: 54896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fluorimetric and densitometric determination of hymecromone in plasma].
    Peterková M; Matousová O; Rejholec V
    Cesk Farm; 1987 Mar; 36(2):61-2. PubMed ID: 3581191
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.